hyaluronate gel for rectal injection (Solesta)
Jump to navigation
Jump to search
Indications
- treatment of fecal incontinence for patients >= 18 years of age
Contraindications
- active inflammatory bowel disease
- immunodeficiency
- previous pelvic irradiation
- significant rectal prolapse
- active infection
- bleeding
- tumors or malformation of the anorectal area
- hemorrhoids
- exsiting implant in the anorectal region
- allergy to hyaluronate-based gel
Dosage
- 2 treatments, consisting of 4 injections each
Adverse effects
- injection area pain & bleeding (most common)
- infection & inflammation of anal tissue (less common)
Procedure
- injected into a layer of tissue beneath the anus lining
More general terms
Additional terms
References
- ↑ FDA NEWS RELEASE: May 27, 2011 FDA approves injectable gel to treat fecal incontinence http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257112.htm